Impact of centralized evaluation of bone marrow histology in systemic mastocytosis.

about

Impact of centralized evaluation of bone marrow histology in systemic mastocytosis.

Item

http://www.wikidata.org/entity/Q55029786

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Impact of centralized evaluation of bone marrow histology in systemic mastocytosis.

@en

Impact of centralized evaluation of bone marrow histology in systemic mastocytosis.

@nl

type

Item

label

Impact of centralized evaluation of bone marrow histology in systemic mastocytosis.

@en

Impact of centralized evaluation of bone marrow histology in systemic mastocytosis.

@nl

prefLabel

Impact of centralized evaluation of bone marrow histology in systemic mastocytosis.

@en

Impact of centralized evaluation of bone marrow histology in systemic mastocytosis.

@nl

P1476

Impact of centralized evaluation of bone marrow histology in systemic mastocytosis.

@en

P2093

Andreas Reiter

http://www.w3.org/2001/XMLSchema#string

Hans-Peter Horny

http://www.w3.org/2001/XMLSchema#string

Juliana Schwaab

http://www.w3.org/2001/XMLSchema#string

Karl Sotlar

http://www.w3.org/2001/XMLSchema#string

Mohamad Jawhar

http://www.w3.org/2001/XMLSchema#string

Nicole Naumann

http://www.w3.org/2001/XMLSchema#string

Peter Valent

http://www.w3.org/2001/XMLSchema#string

Wolf-Karsten Hofmann

http://www.w3.org/2001/XMLSchema#string

P2860

One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes

KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis

SRSF2-p95 hotspot mutation is highly associated with advanced forms of mastocytosis and mutations in epigenetic regulator genes.

Diagnostic criteria and classification of mastocytosis: a consensus proposal.

Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis.

Hematopoietic stem-cell transplantation for advanced systemic mastocytosis.

Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay.

Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.

ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.

Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review.

P304

392-397

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ECI.12607

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas Cross

Georgia Metzgeroth

Alice Fabarius

P577

2016-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

295909612

http://www.w3.org/2001/XMLSchema#string

P698

26914980

http://www.w3.org/2001/XMLSchema#string